TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19797252

Group type: EXPERIMENTAL
Intervention: Electrosurgical dissection (EDS)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Laser extraction
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Electrosurgical dissection (EDS) and Laser extraction
Number of subjects: 74
Study: 16797409

Group type: EXPERIMENTAL
Intervention: IST regimen I (E‐ATG alone)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: IST regimen II (E‐ATG and CSA)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: IST regimen III (E‐ATG, CSA, rhuGM‐CSF, rhuEPO)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: IST regimen IV (rabbit ATG (ATG‐F), CSA, rhuGM‐CSF, rhuEPO)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 142
Study: 12767410

Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention-control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeated measures over time
Number of subjects: 0
Study: 10694834

Group type: EXPERIMENTAL
Intervention: Cortisol 80 mg/day for 5 days
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Cortisol 200 mg/day for 5 days
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Cortisol 80 mg/day
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Cortisol 200 mg/day
Number of subjects: 27
Study: 9386013

Group type: EXPERIMENTAL
Intervention: Reaching movements with wrist movement allowed (kinematically redundant)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Reaching movements with wrist restraint (non-redundant)
Number of subjects: 60
Study: 8222032

Group type: EXPERIMENTAL
Intervention: Oral midazolam 0.75 mg.kg‐1 30 min before separation from parents
Number of subjects: 30

Group type: COMPARATOR
Intervention: Oral or rectal pentobarbitone 2 mg.kg‐1 at 90 min, and morphine 0.2 mg.kg‐1 and atropine 0.02 mg.kg‐1 im at 60 min before separation
Number of subjects: 30
Study: 3776445

Group type: EXPERIMENTAL
Intervention: Epidural morphine (4 mg) started peroperatively
Number of subjects: 18

Group type: COMPARATOR
Intervention: Epidural morphine (4 mg) started postoperatively
Number of subjects: 18
Study: 30224199

Group type: EXPERIMENTAL
Intervention: TIV (full-dose trivalent inactivated influenza vaccine)
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: aTIV (adjuvanted trivalent inactivated influenza vaccine)
Number of subjects: 296

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 296
Study: 27260786

Group type: EXPERIMENTAL
Intervention: Chlamydia trachomatis
Number of subjects: 2
Study: 25632576

Group type: EXPERIMENTAL
Intervention: Medicinal-cake-separated moxibustion combined with acupuncture
Number of subjects: 114

Group type: COMPARATOR
Intervention: Manual acupuncture stimulation combined with wheat-flour-cake separated moxibustion
Number of subjects: 114
Study: 22818965

Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication (LNF)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Laparoscopic Hill repair (LHR)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 102
Study: 20460061

Group type: EXPERIMENTAL
Intervention: Weightbearing multiplanar imaging in patients with lateral hindfoot pain
Number of subjects: 20

Group type: COMPARATOR
Intervention: Weightbearing multiplanar imaging in patients without lateral hindfoot pain
Number of subjects: 20
Study: 17582403

Group type: EXPERIMENTAL
Intervention: Headfirst sperm injection
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Tailfirst sperm injection
Number of subjects: 25

Group type: COMPARATOR
Intervention: Transfer of embryos (either headfirst or tailfirst)
Number of subjects: 25
Study: 15632836

Group type: EXPERIMENTAL
Intervention: St Jude Medical ATG coronary connector system (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hand sewn anastomoses (n = 30)
Number of subjects: 60
Study: 11874944

Group type: EXPERIMENTAL
Intervention: Metformin 850 mg once daily
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Troglitazone 200 mg once daily
Number of subjects: 22
Study: 10197663

Group type: EXPERIMENTAL
Intervention: Nicardipine infusion (0.7 to 1.4 microg x kg(‐1) x min(‐1))
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Nitroglycerin infusion (0.5 to 1 microg x kg(‐1) x min(‐1))
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (neither medication)
Number of subjects: 77
Study: 8536298

Group type: EXPERIMENTAL
Intervention: Instantaneous axis of rotation (IAR) of the C2-3 segment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diagnostic blocks of the C2-3 zygapophysial joint
Number of subjects: 0
Study: 2181103

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Doxapram
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Combination of theophylline and doxapram
Number of subjects: 31
Study: 7000030

Group type: EXPERIMENTAL
Intervention: Imipramine hydrochloride
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Desipramine hydrochloride
Number of subjects: 40

Group type: COMPARATOR
Intervention: Methscopolamine bromide
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 30649523

Group type: EXPERIMENTAL
Intervention: Nutrition-focused MNCH package
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard MNCH package
Number of subjects: 0
Study: 29174079

Group type: EXPERIMENTAL
Intervention: Surfactant administered through a laryngeal mask airway (LMA)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (no surfactant administered, maintained on CPAP)
Number of subjects: 103
Study: 27015158

Group type: EXPERIMENTAL
Intervention: Intervention group (communication of the result and offer of psychiatric evaluation and treatment free of charge; N=56)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group (no feedback on test result for 3 months; N=59)
Number of subjects: 115
Study: 25310220

Group type: EXPERIMENTAL
Intervention: Leg press strength training
Number of subjects: 23

Group type: COMPARATOR
Intervention: No-exercise control
Number of subjects: 23
Study: 22659190

Group type: EXPERIMENTAL
Intervention: Pegylated liposomal doxorubicin (PLD) 30 mg/m² and carboplatin AUC 5 plus bevacizumab 10 mg/kg
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Pegylated liposomal doxorubicin (PLD) and carboplatin plus bevacizumab
Number of subjects: 54
Study: 20424191

Group type: EXPERIMENTAL
Intervention: mCIMT-BiT (6 weeks of modified constraint-induced movement therapy followed by 2 weeks of bimanual task-specific training)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Usual Care (1.5 hours of general physical or occupational therapy weekly plus encouragement to use the affected hand)
Number of subjects: 52
Study: 17700049

Group type: EXPERIMENTAL
Intervention: Nefazodone plus clinical management
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Combination of nefazodone and IPT
Number of subjects: 193

Group type: COMPARATOR
Intervention: Combination of IPT and pill-placebo
Number of subjects: 193
Study: 16267611

Group type: EXPERIMENTAL
Intervention: Tamoxifen for 1 year
Number of subjects: 265

Group type: COMPARATOR
Intervention: Observation for 1 year
Number of subjects: 265
Study: 12383805

Group type: EXPERIMENTAL
Intervention: Argon laser trabeculoplasty (ALT)
Number of subjects: 591

Group type: EXPERIMENTAL
Intervention: Trabeculectomy
Number of subjects: 591
Study: 10355150

Group type: EXPERIMENTAL
Intervention: Pranlukast with 400 microgram of BDP
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (400 microgram BDP alone)
Number of subjects: 41
Study: 11921899

Group type: EXPERIMENTAL
Intervention: Arthroscopic surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Arthrocentesis
Number of subjects: 0
Study: 1935543

Group type: EXPERIMENTAL
Intervention: Pattern electroretinograms with 12' and 30' checkerboard stimuli and 1 c/deg and 2.5 c/deg vertical gratings
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cone electroretinograms elicited by ganzfeld stimulation
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Digital filtering using a bandpass of 1-40 Hz
Number of subjects: 12

Group type: COMPARATOR
Intervention: Broadband analogue-filtered pattern electroretinograms
Number of subjects: 12
Study: 6139100

Group type: EXPERIMENTAL
Intervention: Neuroleptics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clonidine
Number of subjects: 0
Study: 31171436

Group type: EXPERIMENTAL
Intervention: β-blockers
Number of subjects: 91

Group type: COMPARATOR
Intervention: No β-blockers
Number of subjects: 91
Study: 29095992

Group type: EXPERIMENTAL
Intervention: tocilizumab plus MTX
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: tocilizumab
Number of subjects: 317

Group type: COMPARATOR
Intervention: MTX
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: tocilizumab arms
Number of subjects: 317
Study: 26936901

Group type: EXPERIMENTAL
Intervention: Pregnancy Outreach Worker (POW) service
Number of subjects: 1324

Group type: COMPARATOR
Intervention: Standard maternity care (control)
Number of subjects: 1324
Study: 24721447

Group type: EXPERIMENTAL
Intervention: Microbicide gel use
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Trial participation
Number of subjects: 150
Study: 22179440

Group type: EXPERIMENTAL
Intervention: Endoscope-assisted surgery
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 25
Study: 20604701

Group type: EXPERIMENTAL
Intervention: Extended VBRT (36-week)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Standard VBRT (12-week)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Both Extended and Standard VBRT
Number of subjects: 130
Study: 19232163

Group type: EXPERIMENTAL
Intervention: Problem-Based Learning (PBL)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional Lecture
Number of subjects: 40
Study: 15955950

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation (TENS)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 10
Study: 11805771

Group type: EXPERIMENTAL
Intervention: Classic envelope flap
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Modified triangular flap
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Overall result
Number of subjects: 60
Study: 10609207

Group type: EXPERIMENTAL
Intervention: dorzolamide 2%
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: latanoprost 0.005%
Number of subjects: 102

Group type: COMPARATOR
Intervention: control (no treatment)
Number of subjects: 102
Study: 7728364

Group type: EXPERIMENTAL
Intervention: Diagnosis of major depression before admission
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Diagnosis of major depression after detoxification
Number of subjects: 82
Study: 2058054

Group type: EXPERIMENTAL
Intervention: Dynamic Rolling Rod
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (halved frame fitting)
Number of subjects: 0
Study: 7051564

Group type: EXPERIMENTAL
Intervention: Indomethacin, 75 mg daily for 8.5 months (6-13 months)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Levamisole, 150 mg daily for 3 days, two times a month for 14 months (6.5-30 months)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Combined immuno-suppressive and anticoagulant treatment (azathioprin, heparin, acenocoumarol) for 15 months (6-35 months)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 38
Study: 30778687

Group type: COMPARATOR
Intervention: Visual inspection alone
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Radiographic examination
Number of subjects: 126
Study: 29121988

Group type: EXPERIMENTAL
Intervention: Banha-sasim-tang (BST)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25614531

Group type: EXPERIMENTAL
Intervention: Package of measures including regular postcards and problem-solving therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 24361109

Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy (SMT)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo SMT
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo SMT with instructional set
Number of subjects: 110

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 110
Study: 22381065

Group type: EXPERIMENTAL
Intervention: Self-help manual in addition to standard care and treatment
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard care and treatment
Number of subjects: 54
Study: 19576338

Group type: EXPERIMENTAL
Intervention: Beta blockers at both admission and discharge
Number of subjects: 14703

Group type: EXPERIMENTAL
Intervention: Beta blockers at admission only
Number of subjects: 14703

Group type: EXPERIMENTAL
Intervention: Beta blockers at discharge only
Number of subjects: 14703

Group type: EXPERIMENTAL
Intervention: No beta blockers at either point
Number of subjects: 14703

Group type: EXPERIMENTAL
Intervention: Beta blockers prescribed at discharge
Number of subjects: 14703

Group type: EXPERIMENTAL
Intervention: Consistent beta blockers at randomization and discharge
Number of subjects: 14703

Group type: EXPERIMENTAL
Intervention: Beta blockers in patients with impaired and preserved systolic left ventricular function
Number of subjects: 14703

Group type: EXPERIMENTAL
Intervention: Combination of valsartan, captopril, and beta blockers
Number of subjects: 14703
Study: 17284733

Group type: EXPERIMENTAL
Intervention: ALA diet (6.5% of energy)
Number of subjects: 23

Group type: COMPARATOR
Intervention: LA diet (12.6% of energy)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Average American diet (AAD)
Number of subjects: 23
Study: 17979578

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) at doses of 1.25, 2.5, 5, and 7.5 mg administered three times per day (t.i.d.)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study: 15235821

Group type: EXPERIMENTAL
Intervention: Cremophor EL (CrEL) 20 ml/m2 (equivalent to 175 mg/m2 paclitaxel)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 16
Study: 10841226

Group type: EXPERIMENTAL
Intervention: Early symptom‐limited exercise test (ET)
Number of subjects: 1173

Group type: EXPERIMENTAL
Intervention: Troponin T (TnT) levels
Number of subjects: 1173

Group type: EXPERIMENTAL
Intervention: Combination of ET results and TnT levels
Number of subjects: 1173
Study: 9398965

Group type: EXPERIMENTAL
Intervention: 1 mg‐kg‐1 lidocaine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 0.1 microgram‐1.kg‐1.min‐1 PGE1
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 0.1 microgram‐1.kg‐1.min‐1 PGE1 plus injection of 1 mg‐1.kg‐1 lidocaine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 100
Study: 10149693

Group type: EXPERIMENTAL
Intervention: Pediatric bag-mask (PBM)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Adult bag-mask (ABM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Mouth-to-mask (M-Ma)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Airway patency group (n=36)
Number of subjects: 50
Study: 3895752

Group type: EXPERIMENTAL
Intervention: Iotrol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metrizamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Iopamidol
Number of subjects: 0
Study: 31307899

Group type: EXPERIMENTAL
Intervention: Gait Exercise Assist Robot (GEAR)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 26
Study: 27632676

Group type: EXPERIMENTAL
Intervention: Extubation readiness test
Number of subjects: 1042
Study: 26365452

Group type: EXPERIMENTAL
Intervention: 30‐min soft music intervention for 3 days
Number of subjects: 112

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 112
Study: 23206319

Group type: EXPERIMENTAL
Intervention: AZD6765 (150 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 21481253

Group type: EXPERIMENTAL
Intervention: MOVE! treatment plus PDA (PDA+)
Number of subjects: 0

Group type: COMPARATOR
Intervention: MOVE! treatment alone (Standard Care)
Number of subjects: 0
Study: 19835582

Group type: COMPARATOR
Intervention: 0 g of GILP
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 5 g of GILP
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 10 g of GILP
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 20 g of GILP
Number of subjects: 10
Study: 16462287

Group type: EXPERIMENTAL
Intervention: RRV‐TV vaccine during the neonatal period
Number of subjects: 90

Group type: COMPARATOR
Intervention: RRV‐TV vaccine at 2 months of age
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 3-dose schedule initiated in the neonatal period
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 0-2-4 month schedule
Number of subjects: 90
Study: 15313740

Group type: EXPERIMENTAL
Intervention: Below-knee compression elastic stockings (30 to 40 mm Hg at the ankle) for 2 years
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (no elastic stockings)
Number of subjects: 180
Study: 11133631

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2%
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bupivacaine 0.15%
Number of subjects: 60
Study: 9570600

Group type: EXPERIMENTAL
Intervention: 20 mg epidural bupivacaine diluted in 4 mL (0.5%)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 20 mg epidural bupivacaine diluted in 10 mL (0.2%)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 20 mg epidural bupivacaine diluted in 20 mL (0.1%)
Number of subjects: 58
Study: 7831456

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 3279410

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 10
Study: 29052964

Group type: EXPERIMENTAL
Intervention: Brief psychoeducation for caregivers conducted in 4 interactive sessions, once per week.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 0
Study: 28693454

Group type: EXPERIMENTAL
Intervention: JolinchenKids - Fit and Healthy in Daycare program
Number of subjects: 1360

Group type: COMPARATOR
Intervention: Delayed intervention control group
Number of subjects: 1360
Study: 25479050

Group type: EXPERIMENTAL
Intervention: mobile device delivered interactive intervention
Number of subjects: 82

Group type: COMPARATOR
Intervention: paper-and-pencil mood monitoring
Number of subjects: 82
Study: 23480308

Group type: EXPERIMENTAL
Intervention: High-priced cosmeceuticals
Number of subjects: 44

Group type: COMPARATOR
Intervention: More affordable cosmeceuticals
Number of subjects: 44
Study: 21496343

Group type: EXPERIMENTAL
Intervention: Educational intervention consisting of three targeted pictorial messages regarding vaccines; administered by trained community health workers.
Number of subjects: 366

Group type: COMPARATOR
Intervention: General health promotion messages based on Pakistan's Lady Health Worker program curriculum; control group.
Number of subjects: 366
Study: 18166837

Group type: EXPERIMENTAL
Intervention: Educational video (18-minute video about clinical trials)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 126
Study: 16615955

Group type: EXPERIMENTAL
Intervention: Early provision of parenteral amino acids (AA) > or =3 g/kg per day at < or =5 days of life (n = 182)
Number of subjects: 1018

Group type: COMPARATOR
Intervention: Late provision of parenteral amino acids (AA) (n = 836)
Number of subjects: 1018

Group type: EXPERIMENTAL
Intervention: Early provision of parenteral amino acids (AA) (n = 182)
Number of subjects: 1018
Study: 14704633

Group type: EXPERIMENTAL
Intervention: L-arginine 3i2 g/day (group A)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: L-arginine 3i4 g/day (group B)
Number of subjects: 32
Study: 11093966

Group type: EXPERIMENTAL
Intervention: Naltrexone 50 mg daily for 12 weeks
Number of subjects: 175

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 175
Study: 9088819

Group type: EXPERIMENTAL
Intervention: Clonidine 4 micrograms kg‐1
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Midazolam 70 micrograms kg‐1
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 8241697

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (2 mg/kg per day)
Number of subjects: 641

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 641
Study: 3797204

Group type: EXPERIMENTAL
Intervention: Vision plus kinaesthesis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visual
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Kinaesthesis
Number of subjects: 0
Study: 29151280

Group type: EXPERIMENTAL
Intervention: 200 ml of a 1.25 kcal/ml nutrition supplement
Number of subjects: 16

Group type: COMPARATOR
Intervention: High protein nutrition supplement bar
Number of subjects: 16
Study: 26791025

Group type: EXPERIMENTAL
Intervention: Buccal and lingual infiltrations with 4% articaine and 1:100,000 adrenaline
Number of subjects: 52

Group type: COMPARATOR
Intervention: Conventional inferior alveolar nerve block (IANB) with 1.8-ml cartridge of 4% articaine and 1:100,000 epinephrine
Number of subjects: 52
Study: 24825167

Group type: EXPERIMENTAL
Intervention: ABC/3TC+ATV
Number of subjects: 296

Group type: COMPARATOR
Intervention: TDF/FTC+ATV/r
Number of subjects: 296
Study: 24030557

Group type: EXPERIMENTAL
Intervention: Brushing with 1.0 g of Colgate Regular Flavor followed by applying 0.25 g of Tooth Mousse Plus (Group A)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Brushing with 0.25 g of Clinpro Tooth Crème (Group B)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Brushing with 1.0 g of Colgate Regular Flavor (Group C)
Number of subjects: 9
Study: 20681273

Group type: EXPERIMENTAL
Intervention: Xuezhikang Capsule (XZK) at a dose of 60 mg, twice a day, combined with hypotensive drugs
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (hypotensive drugs only)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Xuezhikang Capsule (XZK) combined with hypotensive drugs
Number of subjects: 110
Study: 18184242

Group type: EXPERIMENTAL
Intervention: Introducer Tool (IT)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Gum Elastic Bougie (GEB)
Number of subjects: 124
Study: 16298239

Group type: EXPERIMENTAL
Intervention: Insulin (induced hyperinsulinemia)
Number of subjects: 0